Delivery Order SPE2DB20D2104-SPE2DB24FS53H

Award Date 2/12/24
Potential Completion Date 2/13/24
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,631.40 firm fixed-price contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 13, 2023 and was awarded on November 9, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The award has a ceiling value of $6,500.19 and a completion date of May 22, 2025. The contract is not set aside and is awarded as a delivery order. Amerisourcebergen Drug Corp is the prime contractor, with no...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a medical product, with a ceiling value of $7,633.22 and a period of performance through March 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of QULIPTA 30 MG TABLET 30S, a prescription medication, with a ceiling value of $1,488.28. The contract has an ultimate completion date of May 17, 2024 and was awarded on April 26, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating it...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of QULIPTA 30 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,841.64 and a performance period ending on March 12, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a medication, with a firm fixed price and a ceiling value of $3,833.21. The contract is not set aside and has an ultimate completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,623.91, is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 18, 2024 and is a firm fixed-price delivery order. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, with ID SPE2DX15D2100|SPE2DX24F33FX, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,596.52 firm fixed-price delivery order is for the medical product QULIPTA 60 MG TABLET 30S. The contract has an ultimate completion date of December 8, 2023 and was awarded on December 7, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of QULIPTA 60 MG TABLET 30S. The contract has a ceiling value of $4,194.53 and a period of performance through May 28, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of QULIPTA 30 MG TABLET 30S, a prescription medication. The contract has a ceiling value of $1,726.20 and a period of performance through July 2024. This appears to be a task order awarded under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FS53H
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for QULIPTA 60 MG TABLET 30S. The total ceiling value of the contract is $1,116.21, with a period of performance through February 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC enables Cencora, Inc. to efficiently deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order is a firm fixed-price contract with no set-aside designation, indicating open competition. The contract aligns with the DLA's role in providing medical commodities, including specialty medications, to the Department of Defense and other federal healthcare programs.

Generated 2/27/25, 9:44 AM